Genaissance Pharmaceuticals Announces Scientific Management Changes
NEW HAVEN, Conn. -- Genaissance Pharmaceuticals Inc. (GNSC) said Chief Scientific Officer and co-founder Gualberto Ruano will resign Aug. 31.
A company spokesman wasn't immediately available to comment on the resignation.
In a press release Tuesday, the pharmaceutical company said it named Richard S. Judson to the post.
Judson, 44 years old, was senior vice president, medical affairs and informatics, since August 2000.
Genaissance, which was founded in 1997, posted a 2002 loss of $33.3 million, or $1.46 a share, on revenue of $8.1 million.
The company's shares traded recently at $1.48, down 2 cents, or 1.3%, on Nasdaq volume of 10,600 shares. Average daily volume is 99,076 shares.
Company Web site: genaissance.com |
